Hancock Jaffe Laboratories Inc EPS
Qual é o EPS de Hancock Jaffe Laboratories Inc?
O EPS de Hancock Jaffe Laboratories Inc é N/A
Qual é a definição de EPS?
O lucro por ação (EPS) é a parcela do lucro de uma empresa alocada a cada ação ordinária em circulação. É ajustado para diluição e calculado ao longo de doze meses.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
O que Hancock Jaffe Laboratories Inc faz?
Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.